Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

Y Pommier, O Sordet, S Antony, RL Hayward, KW Kohn - Oncogene, 2004 - nature.com
Intrinsic (innate) and acquired (adaptive) resistance to chemotherapy critically limits the
outcome of cancer treatments. For many years, it was assumed that the interaction of a drug with …

Molecular interaction map of the mammalian cell cycle control and DNA repair systems

KW Kohn - Molecular biology of the cell, 1999 - Am Soc Cell Biol
Eventually to understand the integrated function of the cell cycle regulatory network, we must
organize the known interactions in the form of a diagram, map, and/or database. A diagram …

Repair of and checkpoint response to topoisomerase I-mediated DNA damage

…, ZY Liao, G Kohlhagen, HL Zhang, KW Kohn - Mutation Research …, 2003 - Elsevier
Topoisomerase I (Top1) catalyzes two transesterification reactions: single-strand DNA
cleavage and religation that are normally coupled for the relaxation of DNA supercoiling in …

WAF1/CIP1 Is Induced in p53-mediated G1 Arrest and Apoptosis

…, MB Kastan, KW Kohn, SJ Elledge, KW Kinzler… - Cancer research, 1994 - AACR
The tumor growth suppressor WAF1/CIP1 was recently shown to be induced by p53 and to
be a potent inhibitor of cyclin-dependent kinases. In the present studies, we sought to …

A gene expression database for the molecular pharmacology of cancer

…, M Waltham, LH Smith, JK Lee, L Tanabe, KW Kohn… - Nature …, 2000 - nature.com
We used cDNA microarrays to assess gene expression profiles in 60 human cancer cell
lines used in a drug discovery screen by the National Cancer Institute. Using these data, we …

An information-intensive approach to the molecular pharmacology of cancer

…, PM O'Connor, SH Friend, AJ Fornace Jr, KW Kohn… - Science, 1997 - science.org
Since 1990, the National Cancer Institute (NCI) has screened more than 60,000 compounds
against a panel of 60 human cancer cell lines. The 50-percent growth-inhibitory …

Characterization of the p53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations with the Growth …

…, JN Weinstein, S Friend, AJ Fornace Jr, KW Kohn - Cancer research, 1997 - AACR
In the present study, we report the characterization of the p53 tumor suppressor pathway in
the 60 cell lines of the National Cancer Institute (NCI) anticancer drug screen, as well as …

CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set

WC Reinhold, M Sunshine, H Liu, S Varma, KW Kohn… - Cancer research, 2012 - AACR
High-throughput and high-content databases are increasingly important resources in molecular
medicine, systems biology, and pharmacology. However, the information usually resides …

Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor …

C Jaxel, KW Kohn, MC Wani, ME Wall, Y Pommier - Cancer research, 1989 - AACR
… Pommier, Y., Covey, JM, Kerrigan, D., Mattes, W., Markovits, J., and Kohn, KW Role of DNA
intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-…

X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution

MO Bradley, KW Kohn - Nucleic acids research, 1979 - academic.oup.com
This work presents a neutral filter elution method for detecting DNA double strand breaks in
mouse L1210 cells after X-ray. The assay will detect the number of double strand breaks …